Latest filing published 09 May 2025 for Edwards Lifesciences Corp.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Nicholas J. Valeriani, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Edwards Lifesciences Corp, RTI Surgical, Inc. and Surgalign Holdings, Inc. We count 28 filings; the first trade dates from 13 May 2016 and the latest from 9 May 2025.
Both buying and selling appear: 4 purchases worth €239k, against 1 sale worth €580k. Netting one side against the other leaves €341k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 19 share grants and 2 option exercises.
The median purchase comes to €34k. 3 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 9 May 2025 came the latest disclosure, a share grant in Edwards Lifesciences Corp. The last purchase on record was published on 24 November 2021, which is 1,795 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations